Straits Times Index
3,336.59 +13.21 (+0.40%) S&P 500
5,277.51 +42.03 (+0.80%) Dow
38,686.32 +574.82 (+1.51%) Nasdaq
16,735.02 -2.08 (-0.01%) Bitcoin USD
67,866.73 +121.29 (+0.18%) CMC Crypto 200
1,468.68 +40.11 (+2.81%)
ClearPoint Neuro, Inc. (CLPT)
After hours:
- GlobeNewswire
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
Newly Launched Technology Will Be on Display at ASSFN in Nashville from June 1 - 4 ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System Newly Launched Technology Will Be on Display at ASSFN in Nashville from June 1 - 4 Animation of a ClearPoint Prism Neuro Laser Therapy System SOLANA BEACH, Calif., June 01, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling comp
- GuruFocus.com
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
ClearPoint Neuro showcases a 41% revenue increase and strategic expansions in biologics and capital equipment sectors.
- GlobeNewswire
ClearPoint Neuro Reports First Quarter 2024 Results
First Quarter Revenue Growth +41%; Record Revenue AchievedSOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its first quarter ended March 31, 2024. First Quarter Highlights Reported quarterly revenue of $7.6 million, a 41% year-over-year increase;Increased biologics and drug delivery revenue
